These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32660728)

  • 21. Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol.
    Abdel Raheem A; Capece M; Kalejaiye O; Abdel-Raheem T; Falcone M; Johnson M; Ralph OG; Garaffa G; Christopher AN; Ralph DJ
    BJU Int; 2017 Nov; 120(5):717-723. PubMed ID: 28612401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Collagenase clostridium histolyticum for Peyronie's disease: A new minimally invasive and effective treatment].
    Lin HC; Zhang HT; Jiang H
    Zhonghua Nan Ke Xue; 2017 Sep; 23(9):771-775. PubMed ID: 29726655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of Peyronie's disease with collagenase Clostridium histolyticum in the acute phase.
    El-Khatib FM; Towe M; Yafi FA
    World J Urol; 2020 Feb; 38(2):299-304. PubMed ID: 31093703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuing Collagenase Clostridium Histolyticum Injections Among Initial Nonresponders Results in Significant Curvature Improvements in the Majority of Peyronie's Disease Men.
    Alom M; Burgon H; Ziegelmann M; Köhler T; Helo S; Trost L
    J Sex Med; 2021 Jun; 18(6):1092-1098. PubMed ID: 34020925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-institutional Prospective Analysis of Intralesional Injection of Collagenase Clostridium Histolyticum, Tunical Plication, and Partial Plaque Excision and Grafting for the Management of Peyronie's Disease.
    Yafi FA; Diao L; DeLay KJ; DeYoung L; Talib R; Alzweri L; Brock G; Hellstrom WJG; Hatzichristodoulou G
    Urology; 2018 Oct; 120():138-142. PubMed ID: 30059716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
    Ralph DJ; Abdel Raheem A; Liu G
    J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collagenase Clostridium histolyticum for the pharmacological management of Peyronie's disease.
    Anaissie J; Powers MK; Hellstrom WJ; Yafi FA
    Drugs Today (Barc); 2015 Aug; 51(8):457-68. PubMed ID: 26380384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sixty years in the making: collagenase Clostridium histolyticum, from benchtop to FDA approval and beyond.
    Mills SA; Gelbard MK
    World J Urol; 2020 Feb; 38(2):269-277. PubMed ID: 31168744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies.
    Lipshultz LI; Goldstein I; Seftel AD; Kaufman GJ; Smith TM; Tursi JP; Burnett AL
    BJU Int; 2015 Oct; 116(4):650-6. PubMed ID: 25711400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collagenase clostridium histolyticum: a novel medical treatment for Peyronie's disease.
    Abdel Raheem A; Johnson M; Ralph D; Garaffa G
    Minerva Urol Nefrol; 2018 Aug; 70(4):380-385. PubMed ID: 29761688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term Curvature Deformity Characterization in Men Previously Treated With Collagenase Clostridium Histolyticum for Peyronie's Disease, Subgrouped by Penile Plaque Calcification.
    Goldstein I; McLane MP; Xiang Q; Wolfe HR; Hu Y; Gelbard MK
    Urology; 2020 Dec; 146():145-151. PubMed ID: 32896582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Collagenase Clostridium histolyticum (Xiapex
    Cocci A; Di Maida F; Russo GI; Capogrosso P; Francesco L; Rizzo M; Di Mauro M; Salonia A; Cito G; Falcone M; Romano A; Polloni G; Martinez-Salamanca JI; Fernández-Pascual E; Minervini A; Mondaini N
    Clin Drug Investig; 2020 Jun; 40(6):583-588. PubMed ID: 32342279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
    Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
    J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collagenase Clostridium histolyticum for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic Approach.
    Gelbard MK; Chagan L; Tursi JP
    J Sex Med; 2015 Jun; 12(6):1481-9. PubMed ID: 25940867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
    Hellstrom WJG; Tue Nguyen HM; Alzweri L; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M
    J Urol; 2019 Apr; 201(4):777-782. PubMed ID: 30672843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment-related Outcomes for Patients With Atypical Peyronie's Disease Using Xiaflex Injections.
    El-Khatib FM; Osman MM; Kopelevich A; Towe M; Yafi FA
    Urology; 2020 Sep; 143():153-158. PubMed ID: 32590080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peyronie's disease response to intralesional collagenase clostridium histolyticum therapy is independent of baseline testosterone.
    Schneider D; O'Leary M; Amini E; Miller J; Hassas N; Nguyen J; Hammad MAM; Barham D; Yafi FA
    Andrology; 2024 May; 12(4):830-834. PubMed ID: 37753943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.
    Dhillon S
    Drugs; 2015 Aug; 75(12):1405-12. PubMed ID: 26201462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic advances in the treatment of Peyronie's disease.
    Yafi FA; Pinsky MR; Sangkum P; Hellstrom WJ
    Andrology; 2015 Jul; 3(4):650-60. PubMed ID: 26097120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.